.
MergerLinks Header Logo

Announced

Completed

Datavant completed the merger with Ciox Health in a $7bn deal.

Financials

Edit Data
Transaction Value£4,946m
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

clinical data exchange

United States

Acquisition

Merger

Venture Capital

Domestic

healthcare information technology

IT Services: Other

Private

Friendly

Single Bidder

Private Equity

Completed

medical records

Synopsis

Edit

Datavant, which provides solutions to help institutions protect, match and share health data, completed the merger with Ciox Health, a healthcare information management company, in a $7bn deal. The transaction supported by existing investor group of New Mountain Capital, Roivant Sciences, Transformation Capital, Merck Global Health Innovation Fund, Labcorp, Cigna Ventures, Johnson & Johnson Innovation, Flex Capital, with significant new investment from Sixth Street and Goldman Sachs Asset Management. “Our goal is to create a ubiquitous, trusted, and neutral data ecosystem where parties across the healthcare system can seamlessly and securely exchange data – unlocking better outcomes, faster research, and healthcare at a lower cost. The combined company is positioned to transform America’s health infrastructure and power the health data economy,” Travis May, Datavant CEO.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US